William Maloney
Adult Reconstructive Orthopaedic Surgery · Stanford, CANPI 1255487500
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $10,854,379 of the $11,140,280 with a category attached, or 97.4%. Stryker accounts for 80.7% of it on its own, with 9 other manufacturers making up the rest. Among adult reconstructive orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 457 payments — averaging $24,377 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$9M
- Zimmer Biomet$2M
- Pacira Therapeutics, Inc.$94K
- Heron Therapeutics, Inc.$2K
- Medical Device Business Services, Inc.$586
- Onkos Surgical, Inc.$302
- plus $620 from 4 others
Across 1 payment — averaging $60.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Moximed, Inc$60
What the payments were for
- Royalty or licence$10,854,37997%
- Consulting fees$110,3441%
- Travel & lodging$163,3921%
- Food & beverage$12,1650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 394 | $8,994,719 |
| Zimmer Biomet | 18 | $2,047,734 |
| Pacira Therapeutics, Inc. | 28 | $93,927 |
| Heron Therapeutics, Inc. | 2 | $2,393 |
| Medical Device Business Services, Inc. | 8 | $586 |
| Onkos Surgical, Inc. | 2 | $302 |
| DJO, LLC | 2 | $274 |
| Davol Inc. | 1 | $152 |
| Smith+Nephew | 1 | $121 |
| Johnson & Johnson | 1 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCOLADE$8,807,072
- TRIDENT$5,162,393
- TRIATHLON$4,900,766
- Persona$1,873,594
- A.L.P.S.$174,140
- MAKO$165,043
- Zilretta$48,093
- NEW PRODUCT DEVELOPMENT$6,370
- Zynrelef$2,393
- RESTORATION$1,450
- GMRS$1,350
- FIXOS$493
- ELEOS LIMB SALVAGE SYSTEM$302
- Channel Drain$152
- DONJOY$145
- NONE$126
- AUGMENT INJECTABLE$121
- AXSOS$107
How this compares
$11,140,280 in reported general payments places this provider in the 95th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult reconstructive orthopaedic surgery in Stanford
- James HuddlestonStanford$1.5M
- Derek AmanatullahStanford$828K
- Jessica HooperStanford$145K
- Matthew MillerStanford$93K
- Jason LipofStanford$51K
- Stuart GoodmanStanford$23K
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.